CLEARLINK LUER ACTIVATED VALVE
Report
- Report Number
- 1416980-2020-05657
- Event Type
- Malfunction
- Date Received
- September 14, 2020
- Report Date
- November 4, 2020
- Manufacturer
- BAXTER HEALTHCARE CORPORATION
- Product Code
- FPA
- PMA / PMN Number
- K112893
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MA, US
- Reporter Occupation
- OTHER
Narratives
ADDITIONAL INFORMATION WAS ADDED TO B5, D1, D4, D10, G1, G5, H3 AND H6. B5. THE AFFECTED PRODUCT IS CLEARLINK SYSTEM NON-DEHP SOLUTION SET, PREVIOUSLY SUBMITTED AS ACCESS SETS. D1: BRAND NAME: CLEARLINK LUER ACTIVATED VALVE PREVIOUSLY SUBMITTED AS ¿NI¿. D4: CATALOGUE #: 2R8403 PREVIOUSLY SUBMITTED AS ¿ASKU¿. G1: THE EXACT DEVICE MANUFACTURER INFORMATION WAS ADDED. G5: PMA/510K #: K112893 PREVIOUSLY SUBMITTED AS ¿NI¿. H10: THE ACTUAL SAMPLE WAS RECEIVED FOR EVALUATION. VISUAL INSPECTION WAS PERFORMED USING THE NAKED DID NOT IDENTIFY ANY ABNORMALITIES THAT COULD HAVE CONTRIBUTED TO THE REPORTED CONDITION. DIMENSIONAL TEST AND PULL TEST WAS PERFORMED AND NO ISSUES NOTED. ADDITIONALLY, A FUNCTIONAL LEAK TEST WAS PERFORMED WHICH OBSERVED A CUT SLICE HOLE ON THE TUBING. NO ADDITIONAL DEFECT WAS OBSERVED. THE CAUSE OF THE CUT SLICE HOLE WAS DUE TO A MANUFACTURING RELATED ISSUE. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.
THE DEVICES WERE NOT RETURNED AND THE LOT NUMBER IS UNKNOWN. THEREFORE, A DEVICE ANALYSIS COULD NOT BE COMPLETED. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.
IT WAS REPORTED THAT AN UNKNOWN QUANTITY OF ACCESS SETS HAD A BLUE SLIDE CLAMP THAT BROKE. THIS ISSUE WAS IDENTIFIED DURING AN UNSPECIFIED PROCESS STEP. THERE WAS NO REPORT OF PATIENT INJURY, OR MEDICAL INTERVENTION ASSOCIATED WITH THIS EVENT. NO ADDITIONAL INFORMATION IS AVAILABLE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 993975 | CLEARLINK LUER ACTIVATED VALVE | SET, ADMINISTRATION, INTRAVASCULAR | FPA | BAXTER HEALTHCARE CORPORATION | NA | ASKU |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |